Overall Technical outlook

Price Summary

Concord Biotech Limited had a lousy day at the stock market, and its shares sank -3.35%.
On 2025-04-25, Concord Biotech Limited's stock began at 1643.0, peaked at 1649.5, declined to 1580.0, and ended the day -3.35% down at 1588.0, with 69960 shares traded.
During the 52-week span, the stock hit a high of 2601.1 and a low of 1395.8.
The price projection is between 1620.0 and 2187.0, with an average expected price around 1906.8, according to 5 analysts.

Technicals


Aroon: The AROON is in a neutral stance, with no clear direction indicated for the market. This lack of clarity suggests that the market may be in a state of equilibrium for CONCORDBIO, with no strong trend emerging.
CONCORDBIO aroon abc0b7
Aroon chart for Concord Biotech Limited


Bol. Bands: The BOLL BANDS is showing a neutral stance, with no definitive indication of an upward or downward trend for CONCORDBIO. This neutral position suggests a period of indecision in the market, making it difficult to predict the next move.
CONCORDBIO bbands abc0b7
Bolinger Bands chart for Concord Biotech Limited


Parabolic SAR: The PSAR has just moved from a bullish to a bearish stance, indicating a possible market downturn. If this shift is corroborated by other trends, it could be a very bearish signal. Investors should be cautious and look for additional confirmation before acting.
CONCORDBIO psar abc0b7
Parabolic Stop and Reverse chart for Concord Biotech Limited


Stochastic: The STOCHASTIC is currently in a neutral position for Concord Biotech Limited, offering no clear guidance on whether the market is likely to move up or down. This neutral stance suggests that further observation may be necessary before a trend becomes apparent.
CONCORDBIO stoch abc0b7
Stochastic chart for Concord Biotech Limited


Tripple Moving Agerage: The Tripple MOVING AVG is currently neutral, showing no clear bias toward an upward or downward trend. This suggests that the market may be in a phase of indecision or consolidation.
CONCORDBIO trippleSMA abc0b7
Tripple SMA chart for Concord Biotech Limited


When assessing a company's technical performance, such as stock price fluctuations and trading volume, it is crucial to first examine its fundamentals. These fundamentals include financial health, profitability, and growth potential. Additionally, understanding the industry's dynamics, including competitive pressures and market trends, is key to contextualizing the company's performance. By integrating these factors, a more comprehensive and meaningful analysis can be conducted, leading to more informed investment decisions.